Minovia Therapeutics Ltd. – Trademark Portfolio
Entity Type: 99
Minovia Therapeutics Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MINOVIA and MITOAUGMENT.
3 Ha'sadna st.
3902603 Tirat Karmel
Showing of trademarks Trademarks
Trademark Classifications
Minovia Therapeutics Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Minovia Therapeutics Ltd. have?
Minovia Therapeutics Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Minovia Therapeutics Ltd. file in?
Minovia Therapeutics Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Minovia Therapeutics Ltd.'s most well-known trademarks?
Minovia Therapeutics Ltd.'s registered trademark portfolio includes well-known marks such as MINOVIA and MITOAUGMENT. These are among 2 currently registered trademarks in the portfolio.
What is Minovia Therapeutics Ltd.'s trademark registration success rate?
Minovia Therapeutics Ltd. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.